We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership Extension and US Patent Award

4 Aug 2022 07:00

RNS Number : 8358U
Directa Plus PLC
04 August 2022
 

4th August 2022

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (596/2014) WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Directa Plus extends partnership with Alfredo Grassi S.p.A.

G+® golf ball US patent award

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce that the Company has signed an extension to its commercial supply agreement (the "Supply Agreement") with Alfredo Grassi S.p.A. ("Grassi") to broaden its existing collaboration to include Graphene Plus Thermal Planar Circuit® (PTC®) for the workwear market in Italy and France.

 

Grassi is a leading Italian workwear and outerwear manufacturer, which has been operating since 1925. Grassi focuses on producing technical clothing for industry and in sports and fashion retail, with a strong focus on innovation and sustainability. Directa Plus has been working in partnership with Grassi for over five years.

 

The Supply Agreement grants Grassi use of Directa Plus' proprietary PTC® Graphene Plus print textile technology for the workwear market in France and Italy for a period of two years.

 

Both Directa Plus and Grassi see significant advantages to the Supply Agreement, with Directa Plus gaining a recurring revenue stream on its Graphene Plus PTC® technology, with Grassi benefitting from the use of sustainable Graphene Plus textile technology for the workwear industry, which has no biological / environmental impact, in key markets. The agreement will also enable the Company to further develop its understanding of market trends and drivers affecting demand for such products.

 

The Supply Agreement is expected to be a significant boost to the Company's estimated workwear income in 2022, which is already forecast to be up 100% year on year, with €450,000 orders planned for the second half of 2022.

 

Giulio Cesareo, Chief Executive of Directa Plus, commented: "Grassi has been an important partner of ours for a number of years, and it is clear that both sides see the benefits of continuing to build on our close commercial relationship with each other.

"The workwear sector continues to be of strategic importance to Directa, and the Supply Agreement with Grassi is another important step forward in building market share and increasing revenues from this segment."

 

Roberto Grassi, President of Alfredo Grassi, commented: "This strategic partnership with Directa Plus enables Alfredo Grassi to offer innovative solutions in the workwear industry, providing superior performance, comfort, and better wearability in all our garments. I strongly believe that the involvement of all the stakeholders in the production chain from suppliers to consumers is crucial for the development of innovative and sustainable products. We are very pleased to extend our partnership with Directa Plus and we believe the collaboration will further strengthen the growth of both companies, while keeping a focus on environmental and social sustainability."

 

US Patent award

Additionally, the Company has received the grant of the US patent titled "Golf ball comprising graphene". The patent will enable Directa Plus to license its technology in the critical US market.

 

The patent priority date is the 23rd December 2016, and covers a variety of formulations containing G+® graphene nanoplatelets for application within the golf ball.

 

The use of G+® compounds in golf balls at different loadings has the promise of developing a whole new range of golf balls for professionals and amateurs. Different G+® graphene compounds within the golf ball will enable professionals to increase distance without losing lateral control or increase overall control of the golf ball for amateurs.

 

The global golf ball market was valued at $1.11 billion in 2017, with a forecast CAGR of 2.7% from 2018 onwards.

 

The Company is now looking for partners to bring this leading technology to market.

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Giorgio Bonfanti, CFO

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Adam Rae

 

Singer Capital Markets Securities Limited (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

 

Heather Armstrong

 

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

ends

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGGRVFDGZZM
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.